Back4basebio PLC Overview

4basebio PLC Current Assets

4basebio PLC's current assets is $17M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$17.24M
↓ 39.93% YoYΔ $-11.46M vs prior year quarter

Peer trimmed avg / median

Loading

4basebio PLC Current Assets History

Loading

4basebio PLC vs. peers: Current Assets Comparison

Loading

4basebio PLC Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

4basebio PLC (4BB.L) FAQ

4basebio PLC posts a current assets of $17M as of June 2026. That compares with $29M in the prior-year period — down 39.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, 4basebio PLC's current assets was $29M. The latest reading is $17M — a 39.9% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of 4basebio PLC's financial statement story. At $17M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4BB.L's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; 4basebio PLC's other metric pages and overview cover the third.

Judging 4basebio PLC against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $17M here, then scan peer and history charts to see if the gap is persistent.